• tyc7111cc太阳成集团

    洞察市场格局
    解锁药品研发情报

    免费客服电话

    18983288589
    医药数据查询

    【ChiCTR1900020656】Effectiveness of a mhealth Intervention for Increasing Colonoscopy Uptake among Chinese First-degree Relatives of People with Colorectal Cancer

    基本信息
    登记号

    ChiCTR1900020656

    试验状态

    尚未开始

    药物名称

    /

    药物类型

    /

    规范名称

    /

    首次公示信息日的期

    2019-01-12

    临床申请受理号

    /

    靶点

    /

    适应症

    結直腸癌

    试验通俗题目

    Effectiveness of a mhealth Intervention for Increasing Colonoscopy Uptake among Chinese First-degree Relatives of People with Colorectal Cancer

    试验专业题目

    Effectiveness of a mhealth Intervention for Increasing Colonoscopy Uptake among Chinese First-degree Relatives of People with Colorectal Cancer

    申办单位信息
    申请人联系人
    申请人名称
    联系人邮箱
    联系人邮编

    联系人通讯地址
    临床试验信息
    试验目的

    This study aims to develop a tailored risk communication intervention (TRCI) based on results of the systematic review on interventions to promote colonoscopy screening conducted by the principal investigator, and examine its effectiveness in promoting colonoscopy uptake among Chinese first-degree relatives (FDRs).

    试验分类
    试验类型

    随机平行对照

    试验分期

    卫生服务研究

    随机化

    Each family will be randomly assigned to TRSI group or control group with a 1:1 ratio using a sequence of block randomization number to assign cluster numbers equally to each group. A statistician will generates a random number sequence by computer software, a randomly mixed block size at 4-8 will b

    盲法

    Due to the nature of the intervention, blinding of participants and researchers is impossible. To avoid biased estimated of treatment effect, online survey will be conducted.?Participant will submit the web form back to the web server directly when the finish the assessment and the intervener are not able to influence the assessment.

    试验项目经费来源

    N/A

    试验范围

    /

    目标入组人数

    105

    实际入组人数

    /

    第一例入组时间

    2019-03-04

    试验终止时间

    2019-10-31

    是否属于一致性

    /

    入选标准

    (1) aged 40-75 years or 10 years before the age the relative was diagnosed; (2) individuals with 1 FDR with CRC at <60 years or with 2 or more FDRs with CRC at any age; (3) have not had a colonoscopy before; (4) with access to We-chat themselves or through close family members living in the same household; (5)able to read and speak Chinese. (6) living in Shenzhen；

    排除标准

    (1) have history of cancer or inflammatory bowel disease; (2) recently participate in another study or previously participated in cancer risk counseling or study; (3) with doctor-diagnosed psychiatric illness.；

    研究者信息
    研究负责人姓名
    试验机构

    香港中文大學醫學院那打素護理學院

    研究负责人电话
    研究负责人邮箱
    研究负责人邮编

    /

    联系人通讯地址

    香港中文大學的其他临床试验

    更多

    最新临床资讯

    tyc7111cc太阳成集团企业版
    50亿+条医药数据随时查
    7天免费试用
    体验产品